January 6 th, 2010 Ju Han Imaging & Informatics Lab Life Sciences Division Molecular Predictors of 3D Morphogenesis by Breast Cancer.

Slides:



Advertisements
Similar presentations
Gene Set Enrichment Analysis Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein.
Advertisements

Gene Set Enrichment Analysis Genome 559: Introduction to Statistical and Computational Genomics Elhanan Borenstein.
Data Integration for Cancer Genomics. Personalized Medicine Tumor Board Question: given all we know about a patient, what is the “optimal” treatment?
MiRNA-drug resistance mechanisms Summary Hypothesis: The interplay between miRNAs, signaling pathways and epigenetic and genetic alterations are responsible.
27803::Systems Biology1CBS, Department of Systems Biology Schedule for the Afternoon 13:00 – 13:30ChIP-chip lecture 13:30 – 14:30Exercise 14:30 – 14:45Break.
Part II: Discriminative Margin Clustering Joint work with: Rob Tibshirani, Dept of Statistics Patrick O. Brown, School of Medicine Stanford University.
Alizadeh et. al. (2000) Stephen Ayers 12/2/01. Clustering “Clustering is finding a natural grouping in a set of data, so that samples within a cluster.
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Supplemental. Supplemental Figure 1. iPSC-EC expression and function. (A) Low density lipoprotein (LDL) uptake as performed using standard assay technique.
DNA Microarrays Examining Gene Expression. Prof. GrossBiology 4 DNA MicroArrays DNA MicroArrays use hybridization technology to examine gene expression.
Analysis of GO annotation at cluster level by H. Bjørn Nielsen Slides from Agnieszka S. Juncker.
Introduction The goal of translational bioinformatics is to enable the transformation of increasingly voluminous genomic and biological data into diagnostics.
Graph-based consensus clustering for class discovery from gene expression data Zhiwen Yum, Hau-San Wong and Hongqiang Wang Bioinformatics, 2007.
Gene expression profiling identifies molecular subtypes of gliomas
Table S1. Characteristics of breast tumor and normal breast tissue samples. Relevant characteristics of breast tumor and normal breast tissue samples analyzed.
Lentiviral shRNA screen to test the validity of a gene signature of breast cancer stem cells using high throughput mammosphere assays Jenny Chang Lab.
FUNCTIONAL GENOMICS REVEAL THAT THE SERINE SYNTHESIS PATHWAY IS ESSENTIAL IN BREAST CANCER Introduction: Tim Butler Spellman Lab.
Understanding cell state with quantitative live cell imaging Copyright © 2000 Cell Press. The Hallmarks of Cancer Douglas Hanahan and Robert A. Weinberg.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
Construction of cancer pathways for personalized medicine | Presented By Date Construction of cancer pathways for personalized medicine Predictive, Preventive.
SP Cancer Metastasis Summary Hypothesis: We hypothesize that miRNAs regulate breast cancer cell invasiveness and metastasis by synergistically targeting.
Use of live cell microscopy to follow the temporal regulation of gene expression October 6 th, 2009 Michael Halter, Joe Chalfoun, Antonio Cardone, Benjamin.
Metabolomics Metabolome Reflects the State of the Cell, Organ or Organism Change in the metabolome is a direct consequence of protein activity changes.
Determining the Effect of Triclosan on the Growth of Cancer Cells Lydia Alf and Winnifred Bryant Ph. D. Department of Biology University of Wisconsin,
FLEXGene Repository Applications. Exploiting FLEXGene Genes FLEXGene Clones Expression Clones Proteins Protein Expression Localization Interaction Functional.
Jan 18, 2008 Ju Han, Hang Chang, Mary Helen Barcellos-Hoff, and Bahram Parvin Lawrence Berkeley National Laboratory Multivariate.
Analysis of GO annotation at cluster level by Agnieszka S. Juncker.
The Effect of N-Acetyl Cysteine on Myofibroblast Phenotype Expression by Immortalized Keratinocytes, Ker-CT-Ras Jessica M. Webb 1, Pritika Khadka 2, and.
While gene expression data is widely available describing mRNA levels in different cancer cells lines, the molecular regulatory mechanisms responsible.
Prof. Yechiam Yemini (YY) Computer Science Department Columbia University (c)Copyrights; Yechiam Yemini; Lecture 2: Introduction to Paradigms 2.3.
Lawrence W. C. Chan, Cesar Wong, Fei Meng, Fengfeng Wang, Lili Wang, Benjamin Y. M. Yung Department of Health Technology & Informatics The Hong Kong Polytechnic.
Products > SKNAS Transfection Reagent (Neuroblastoma Cells) Altogen Biosystems offers the SKNAS Transfection Reagent among a host of 100+ cell line specific.
Altogen Biosystems offers the Transfection Reagent for PANC-1 Cells Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection.
Products > 293T/17 Transfection Reagent (Embryonic Kidney Cells, CRL-11268) Altogen Biosystems offers the 293T/17 Transfection Reagent among a host of.
Altogen Biosystems offers the J774A Transfection Reagent among a host of 100+ cell line specific In Vitro Transfection Kits. The J774A Transfection Reagent.
Products > Transfection Reagent for BMS/BMS2 Cells (Bone Marrow Cells) Altogen Biosystems offers the BMS2 Transfection Reagent among a host of 100+ cell.
Products > MCF-7 Transfection Reagent (Breast Cancer, HTB-22) Altogen Biosystems offers the MCF-7 Transfection Reagent among a host of 100+ cell line specific.
Products > Transfection Reagent for C6 Cells (Glioma Cells, CCL-107) Altogen Biosystems offers the C6 Transfection Reagent among a host of 100+ cell line.
Products > HCC1937 Transfection Reagent (Breast Carcinoma) Altogen Biosystems offers the HCC1937 Transfection Reagent among a host of 100+ cell line specific.
A conditional feedback loop regulates Ras activity through EphA2
A Novel Cinnamide YLT26 Induces Breast Cancer Cells Apoptosis via ROS-Mitochondrial Apoptotic Pathway in Vitro and Inhibits.
Products > 4T1 Transfection Reagent (Breast Cancer Cells, CRL-2539)
Products > Capan-1 Transfection Reagent (Pancreatic Carcinoma)
Products > BT-20 Transfection Reagent (Breast Carcinoma Cells)
Products > PC-12 Transfection Reagent (Rat Pheochromocytoma Cells)
Products > Fibroblast Transfection Reagent (Fibroblast Cells)
Altogen labs Leading Developer and Manufacturer of In Vivo and DNA Transfection Kits, Transfection Reagents and Electroporation Delivery Products Products.
Targeting DNA Replication before it Starts
Products > MIA PaCa-2 Transfection Reagent (Pancreatic Carcinoma)
Multidimensional Drug Profiling By Automated Microscopy
Triple‐negative breast cancer (TNBC) cells in human express a specific gene signature and their self‐renewal depends on canonical Wnt/β‐catenin signalling.A.Human.
Fig. 1. PARPi and MEKi induce inverse adaptive responses.
Schedule-dependent interaction between anticancer treatments
Products > ZR-75-1 Transfection Reagent (Breast Carcinoma, CRL1500)
2. Chemistry Department, Faculty of Science, Cairo University.
Volume 146, Issue 4, Pages (August 2011)
Volume 54, Issue 6, Pages (January 1998)
Volume 18, Issue 1, Pages (January 2017)
Volume 17, Issue 8, Pages (November 2016)
Products > NCI-H23 Transfection Reagent (Lung Adenocarcinoma)
Volume 20, Issue 4, Pages (October 2011)
Volume 23, Issue 5, Pages (May 2016)
A conditional feedback loop regulates Ras activity through EphA2
Gene signatures of wild‐type cells upon stimulation
Identification of aging-related genes and affected biological processes. Identification of aging-related genes and affected biological processes. (A) Experimental.
Molecular Therapy - Methods & Clinical Development
Clustering analysis of DTC-associated genes.
Effect of bevacizumab on the proliferation of A2780 cells.
Volume 28, Issue 4, Pages e6 (July 2019)
Presentation transcript:

January 6 th, 2010 Ju Han Imaging & Informatics Lab Life Sciences Division Molecular Predictors of 3D Morphogenesis by Breast Cancer Cells in 3D Culture

January 6 th, 2010 Outline Motivation Experimental design Previous work Approach Results Summary

January 6 th, 2010 Motivation A panel of cell lines for analysis Morphometric subtyping for a panel of breast cancer cell lines in identifying —subpopulations with similar morphometric properties —molecular predictors for each subpopulations —Introduce necessary molecular diversity —Generate heterogeneous responses to the treatment —Offer an improved model system for high-content screening, comparative analysis, and cell systems biology

January 6 th, 2010 Experimental design A panel of 24 breast cancer cell lines —600MPE, AU565, BT474, BT483, BT549, CAMA1, HCC1569, HCC70, HS578T, MCF12A, MCF7, MDAMB231, MDAMB361, MDAMB415, MDAMB436, MDAMB453, MDAMB468, S1, SKBR3, T4, T47D, UACC812, ZR751, ZR75B All 3D cell cultures were maintained for 4 days with media change every 2 days, and samples were then imaged with phase contrast microscopy Computational pipeline —Colony segmentation and representation —Phenotypic clustering —Molecular predictor of morphometric clusters —Molecular predictor of morphometric features

January 6 th, 2010 Previous work (Kenny et. al, Gene Ontology, 2007)

January 6 th, 2010 Automatic subtyping a panel of breast cancer cell lines in 3D culture Panel of cell lines Segmentation Morphogenesis indices Consensus clustering Gene expression Molecular predictors for phenotypic subpopulations Molecular predictors of morphogenesis

January 6 th, 2010 Colony segmentation and representation (phase images) Colonies are separated from the background based on texture features; Morphometric features (size and shape) are extracted for each colony.

January 6 th, 2010 Clustering of morphometric features Consensus clustering —A proven method in analyzing gene expression data (Monti et. al, Machine Learning 2003) —Repeated random resampling —Determine the number of clusters by evaluating the consensus distribution for different cluster numbers Challenges —Morphometric features are heterogeneous for the same cell line —Sample size varies for different cell lines —there is no prior knowledge of the number of clusters Repeat for different n Repeat Select the number of clusters, n K-means clustering into n clusters Randomly select equal number of samples from each cell line Similarity matrix: elements are computed from the Kolmogorov-Smirnov (KS) test of the sample label distributions between every pair of cell lines Compute the consensus similarity matrix for cluster number, n

January 6 th, 2010 Consensus clustering on a panel of 24 breast cancer cell lines in 3D N=2N=3N=4 N=5 CDF %change of CDF area

January 6 th, 2010 Results with three clusters Consistent with previous manual clustering results (Kenny et. al, Gene Ontology, 2007) All triple-negative: estrogen receptors, progesterone receptors, and HER2 8 out of 9 cell lines express high levels of ERBB2

January 6 th, 2010 Molecular predictors of morphometric clusters Heat maps of top selected genes that best predict each of the three morphometric clusters —Gene ranking based on moderated t-test RoundGrape-likeStellate

January 6 th, 2010 Best genes for predicting the stellate cluster implicated in the pathway of many diseases including cancer affects the epithelial-mesenchymal transition in cancer affects cell morphogenesis involved in differentiation

January 6 th, 2010 Molecular predictors of morphometric features (colony size) Nonlinear correlation (logistic )

January 6 th, 2010 Discussion The gene expression profiles of the stellate colonies are the most distinct from the other two morphometric classes PPAR-gamma —A druggable target, and a hub for lipid metabolism —A nuclear receptor protein, functions as transcription factors, and can be spliced in multiple forms —A potent inducer of epithelial mesenchymal transition in intestinal epithelial cells —Involved in proliferation and differentiation —Shown to be highly expressed in metastasized human breast tissue

January 6 th, 2010 Validation 1: In vitro experiment on PPARG MDAMB231 was assayed in 3D cell cultures maintained in H14 medium with 1% fetal bovine serum The 3D cultures were prepared in triplicate by seeding single cells on top of a thin layer of Matrigel at a density of 2200 cells/cm2 and overlaid by 5% final Matrigel diluted in culture medium GW9662, a PPARG inhibitor, was dissolved in DMSO and added to the 3D cultures in the final concentration of 10 uM at the time of seeding The vehicle control was pure DMSO The culture medium and the drug were changed every other day Five images per well were collected after five full days in 3D culture

January 6 th, 2010 In vitro validation results Treatment of a MDA-MB-231 with a PPARG-inhibitor indicates reduction in the proliferation rate: (A) untreated line, (B) treatment with Gw-9662, and (C) Proliferation index. The proliferation index was determined by incubating cultures with cell proliferation analysis reagent, WST1, on Day 5.

January 6 th, 2010 Validation 2: In vivo experiment on PPARG

January 6 th, 2010 Summary A system for identifying sub-populations for a panel of breast cancer cell lines These subpopulations are shown to compare well with previously manual clustering of the same data Robust statistics in —identifying those genes that differentiated computed sub- populations —determining genes that track with a specific morphometric feature Associative studies indicated that PPAR-gamma, a druggable target, correlates with the colony size and is highly expressed in the stellate subpopulation To appear in PLoS Computational Biology

January 6 th, 2010 Acknowledgement LBNL Parvin Lab —Hang Chang —Gerald Fontenay —Bahram Parvin Bissell Lab —Genee Lee —Paraic Kenny —Mina Bissell Joe Gray Albert Einstein College of Medicine Kenny Lab —Orsi Giricz —Paraic Kenny UCSF Frederick Baehner Funding NIH ICBP

January 6 th, 2010 Thank you!